Loading...

Richard B Pollard, MD

Title(s)Professor, Infectious Diseases, Medical Microbiology and Immunology
SchoolUniversity of California, Davis
Address4150 V St
CA 95817
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapy. AIDS. 2019 12 01; 33(15):2289-2298. Sainz T, Serrano-Villar S, Mann S, Ma ZM, Utay NS, Thompson CG, Chun TW, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Moreno S, Pollard RB, Landay A, Miller CJ, Asmuth DM. PMID: 31764094.
      View in: PubMed   Mentions:    Fields:    
    2. Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation. mSphere. 2018 11 07; 3(6). Matassoli FL, Leão IC, Bezerra BB, Pollard RB, Lütjohann D, Hildreth JEK, Arruda LB. PMID: 30404938.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    3. Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial. Clin Nutr. 2019 06; 38(3):1303-1309. Shivakoti R, Ewald ER, Gupte N, Yang WT, Kanyama C, Cardoso SW, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo U, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Pollard R, Detrick B, Balagopal A, Asmuth DM, Semba RD, Campbell TB, Golub J, Gupta A. PMID: 29885777.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    4. Temporal Trends in Difficult and Failed Tracheal Intubation in a Regional Community Anesthetic Practice. Anesthesiology. 2018 03; 128(3):502-510. Schroeder RA, Pollard R, Dhakal I, Cooter M, Aronson S, Grichnik K, Buhrman W, Kertai MD, Mathew JP, Stafford-Smith M. PMID: 29189209.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants. Ther Drug Monit. 2017 12; 39(6):596-603. Bednasz CJ, Venuto CS, Ma Q, Daar ES, Sax PE, Fischl MA, Collier AC, Smith KY, Tierney C, Yang Y, Wilding GE, Morse GD. PMID: 29135907.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    6. Associations of Plasma Cytokine and Microbial Translocation Biomarkers With Immune Reconstitution Inflammatory Syndrome. J Infect Dis. 2017 11 27; 216(9):1159-1163. George V, Harrison L, Roach M, Li XD, Tierney C, Fischl MA, Aberg J, Tebas P, Asmuth DM, Pollard RB, Godfrey C, Pahwa S. PMID: 29040604.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy. J Infect Dis. 2017 10 17; 216(7):813-818. Asmuth DM, Thompson CG, Chun TW, Ma ZM, Mann S, Sainz T, Serrano-Villar S, Utay NS, Garcia JC, Troia-Cancio P, Pollard RB, Miller CJ, Landay A, Kashuba AD. PMID: 28968888.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial. EBioMedicine. 2017 Oct; 24:195-204. Huang Y, Pantaleo G, Tapia G, Sanchez B, Zhang L, Trondsen M, Hovden AO, Pollard R, Rockstroh J, Ökvist M, Sommerfelt MA. PMID: 28970080.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    9. Hypotensive Transfusion Reaction Treated With Vasopressin in a Patient Taking an Angiotensin-Converting Enzyme Inhibitor: A Case Report. A A Case Rep. 2017 Jul 01; 9(1):4-8. Pollard R, Boraski M, Block JG. PMID: 28368902.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog. 2017 May; 13(5):e1006368. Serrano-Villar S, Sainz T, Ma ZM, Utay NS, Wook-Chun T, Mann S, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Deeks SG, Landay A, Pollard RB, Miller CJ, Moreno S, Asmuth DM. PMID: 28467485.
      View in: PubMed   Mentions:    Fields:    
    11. Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog. 2016 Mar; 12(3):e1005540. Serrano-Villar S, Sainz T, Ma ZM, Utay NS, Chun TW, Mann S, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Deeks SG, Landay A, Pollard RB, Miller CJ, Moreno S, Asmuth DM. PMID: 27015639.
      View in: PubMed   Mentions: 5     Fields:    
    12. Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog. 2016 Jan; 12(1):e1005381. Serrano-Villar S, Sainz T, Ma ZM, Utay NS, Chun TW, Wook-Chun T, Mann S, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Deeks SG, Landay A, Pollard RB, Miller CJ, Moreno S, Asmuth DM. PMID: 26795282.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    13. Peginterferon a-2a for the treatment of HIV infection. Expert Opin Investig Drugs. 2016; 25(2):249-57. Asmuth DM, Utay NS, Pollard RB. PMID: 26667398.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    14. Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort Study. J Acquir Immune Defic Syndr. 2015 Oct 01; 70(2):163-71. Balagopal A, Asmuth DM, Yang WT, Campbell TB, Gupte N, Smeaton L, Kanyama C, Grinsztejn B, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo UG, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Li XD, Pollard RB, Semba RD, Thomas DL, Bollinger RC, Gupta A. PMID: 26017661.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    15. C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. PLoS One. 2015; 10(2):e0117424. Tenforde MW, Gupte N, Dowdy DW, Asmuth DM, Balagopal A, Pollard RB, Sugandhavesa P, Lama JR, Pillay S, Cardoso SW, Pawar J, Santos B, Riviere C, Mwelase N, Kanyama C, Kumwenda J, Hakim JG, Kumarasamy N, Bollinger R, Semba RD, Campbell TB, Gupta A. PMID: 25719208.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    16. Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164. HIV Clin Trials. 2014 Jul-Aug; 15(4):133-9. Grant PM, Komarow L, Sanchez A, Sattler FR, Asmuth DM, Pollard RB, Zolopa AR. PMID: 25143022.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. A genotypic HIV-1 proviral DNA coreceptor tropism assay: characterization in viremic subjects. AIDS Res Ther. 2014; 11:14. Brown J, Burger H, Weiser B, Pollard RB, Li XD, Clancy LJ, Baumann RE, Rogers AA, Hamdan HB, Pesano RL, Kagan RM. PMID: 24904682.
      View in: PubMed   Mentions: 4     Fields:    
    18. Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2014 Apr; 14(4):291-300. Pollard RB, Rockstroh JK, Pantaleo G, Asmuth DM, Peters B, Lazzarin A, Garcia F, Ellefsen K, Podzamczer D, van Lunzen J, Arastéh K, Schürmann D, Clotet B, Hardy WD, Mitsuyasu R, Moyle G, Plettenberg A, Fisher M, Fätkenheuer G, Fischl M, Taiwo B, Baksaas I, Jolliffe D, Persson S, Jelmert O, Hovden AO, Sommerfelt MA, Wendel-Hansen V, Sørensen B. PMID: 24525316.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCellsCTClinical Trials
    19. Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial. J Acquir Immune Defic Syndr. 2013 Dec 01; 64(4):351-9. Rodriguez B, Asmuth DM, Matining RM, Spritzler J, Jacobson JM, Mailliard RB, Li XD, Martinez AI, Tenorio AR, Lori F, Lisziewicz J, Yesmin S, Rinaldo CR, Pollard RB. PMID: 24169120.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    20. Chronic HIV infection enhances the responsiveness of antigen presenting cells to commensal Lactobacillus. PLoS One. 2013; 8(8):e72789. Nagy LH, Grishina I, Macal M, Hirao LA, Hu WK, Sankaran-Walters S, Gaulke CA, Pollard R, Brown J, Suni M, Baumler AJ, Ghanekar S, Marco ML, Dandekar S. PMID: 24023646.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    21. Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction. AIDS. 2013 Jun 19; 27(10):1563-71. Kalayjian RC, Spritzler J, Matining RM, Fiscus SA, Gross BH, Francis IR, Pollard RB, Lederman MM, Landay A. PMID: 24047762.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    22. Refractory AIDS cholangiopathy: metabolic complications and the role of plasmapheresis. AIDS. 2013 Apr 24; 27(7):1193-4. Allen ME, Brown J, Karakas SE, Pollard RB. PMID: 23902924.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Impact of highly active antiretroviral therapy initiation on CD4(+) T-cell repopulation in duodenal and rectal mucosa. AIDS. 2013 Mar 27; 27(6):867-77. Hayes TL, Asmuth DM, Critchfield JW, Knight TH, McLaughlin BE, Yotter T, McConnell DH, Garcia JC, Pollard RB, Shacklett BL. PMID: 23262500.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    24. HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels. Arterioscler Thromb Vasc Biol. 2013 Feb; 33(2):387-92. Enkhmaa B, Anuurad E, Zhang W, Abbuthalha A, Li XD, Dotterweich W, Pollard RB, Asmuth DM, Berglund L. PMID: 23202367.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    25. Short communication: HIV+ viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation. AIDS Res Hum Retroviruses. 2013 Jan; 29(1):172-7. Shaw JM, Hunt PW, Critchfield JW, McConnell DH, Garcia JC, Pollard RB, Somsouk M, Deeks SG, Shacklett BL. PMID: 22998457.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    26. Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164. J Infect Dis. 2012 Dec 01; 206(11):1715-23. Grant PM, Komarow L, Lederman MM, Pahwa S, Zolopa AR, Andersen J, Asmuth DM, Devaraj S, Pollard RB, Richterman A, Kanthikeel S, Sereti I. PMID: 23002445.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    27. T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384. PLoS One. 2012; 7(8):e43803. Hulgan T, Robbins GK, Kalams SA, Samuels DC, Grady B, Shafer R, Murdock DG, Selph D, Haas DW, Pollard RB. PMID: 22970105.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    28. Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens. AIDS. 2012 Aug 24; 26(13):1625-34. Asmuth DM, Ma ZM, Mann S, Knight TH, Yotter T, Albanese A, Melcher GP, Troia-Cancio P, Hayes T, Miller CJ, Pollard RB. PMID: 22820612.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    29. Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings. PLoS Med. 2012; 9(8):e1001290. Campbell TB, Smeaton LM, Kumarasamy N, Flanigan T, Klingman KL, Firnhaber C, Grinsztejn B, Hosseinipour MC, Kumwenda J, Lalloo U, Riviere C, Sanchez J, Melo M, Supparatpinyo K, Tripathy S, Martinez AI, Nair A, Walawander A, Moran L, Chen Y, Snowden W, Rooney JF, Uy J, Schooley RT, De Gruttola V, Hakim JG. PMID: 22936892.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    30. HIV infection and atherosclerosis: evaluating the drivers of inflammation. Eur J Prev Cardiol. 2013 Oct; 20(5):720-8. Maniar A, Ellis C, Asmuth D, Pollard R, Rutledge J. PMID: 22556374.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    31. Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a. J Infect Dis. 2012 May 01; 205(9):1443-7. Hubbard JJ, Greenwell-Wild T, Barrett L, Yang J, Lempicki RA, Wahl SM, Asmuth DM, Murphy RL, Pollard RB, Kottilil S. PMID: 22454462.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    32. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector. J Virol. 2012 May; 86(10):5719-29. Walker JE, Chen RX, McGee J, Nacey C, Pollard RB, Abedi M, Bauer G, Nolta JA, Anderson JS. PMID: 22398281.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    33. Interferon-alpha administration enhances CD8+ T cell activation in HIV infection. PLoS One. 2012; 7(1):e30306. Manion M, Rodriguez B, Medvik K, Hardy G, Harding CV, Schooley RT, Pollard R, Asmuth D, Murphy R, Barker E, Brady KE, Landay A, Funderburg N, Sieg SF, Lederman MM. PMID: 22291932.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCellsCTClinical Trials
    34. Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384. J Acquir Immune Defic Syndr. 2011 Dec 01; 58(4):363-70. Grady BJ, Samuels DC, Robbins GK, Selph D, Canter JA, Pollard RB, Haas DW, Shafer R, Kalams SA, Murdock DG, Ritchie MD, Hulgan T. PMID: 21792066.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    35. Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers. J Virol. 2011 Nov; 85(21):11422-34. Shaw JM, Hunt PW, Critchfield JW, McConnell DH, Garcia JC, Pollard RB, Somsouk M, Deeks SG, Shacklett BL. PMID: 21880771.
      View in: PubMed   Mentions: 49     Fields:    Translation:Cells
    36. Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation. J Acquir Immune Defic Syndr. 2011 Aug 15; 57(5):363-70. Ellis CL, Ma ZM, Mann SK, Li CS, Wu J, Knight TH, Yotter T, Hayes TL, Maniar AH, Troia-Cancio PV, Overman HA, Torok NJ, Albanese A, Rutledge JC, Miller CJ, Pollard RB, Asmuth DM. PMID: 21436711.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    37. A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment. J Interferon Cytokine Res. 2011 Jun; 31(6):481-3. Bosch RJ, Pollard RB, Landay A, Aga E, Fox L, Mitsuyasu R. PMID: 21291323.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    38. AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein. J Infect Dis. 2010 Sep 01; 202(5):705-16. Schooley RT, Spritzler J, Wang H, Lederman MM, Havlir D, Kuritzkes DR, Pollard R, Battaglia C, Robertson M, Mehrotra D, Casimiro D, Cox K, Schock B. PMID: 20662716.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCellsPHPublic Health
    39. Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses. J Acquir Immune Defic Syndr. 2010 Sep; 55(1):39-48. Lennox JL, Dejesus E, Berger DS, Lazzarin A, Pollard RB, Ramalho Madruga JV, Zhao J, Wan H, Gilbert CL, Teppler H, Rodgers AJ, Barnard RJ, Miller MD, Dinubile MJ, Nguyen BY, Leavitt R, Sklar P. PMID: 20404738.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    40. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses. J Virol. 2010 Nov; 84(21):11020-9. Ferre AL, Hunt PW, McConnell DH, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. PMID: 20719952.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    41. Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328). AIDS Res Ther. 2010 Aug 05; 7:30. Bosch RJ, Pollard RB, Landay A, Aga E, Fox L, Mitsuyasu R. PMID: 20687947.
      View in: PubMed   Mentions: 3     Fields:    
    42. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers. J Virol. 2010 Oct; 84(19):10354-65. Ferre AL, Lemongello D, Hunt PW, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. PMID: 20668079.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    43. Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181. Clin Vaccine Immunol. 2010 Sep; 17(9):1452-9. Macatangay BJ, Zheng L, Rinaldo CR, Landay AL, Pollard RB, Pahwa S, Lederman MM, Bucy RP. PMID: 20631337.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    44. Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. J Infect Dis. 2010 Jun 15; 201(12):1796-805. Kalayjian RC, Machekano RN, Rizk N, Robbins GK, Gandhi RT, Rodriguez BA, Pollard RB, Lederman MM, Landay A. PMID: 20446847.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCells
    45. Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir. AIDS Res Hum Retroviruses. 2010 Jun; 26(6):635-43. Crawford KW, Spritzler J, Kalayjian RC, Parsons T, Landay A, Pollard R, Stocker V, Lederman MM, Flexner C. PMID: 20560793.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    46. Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial. J Infect Dis. 2010 Jun 01; 201(11):1686-96. Asmuth DM, Murphy RL, Rosenkranz SL, Lertora JJ, Kottilil S, Cramer Y, Chan ES, Schooley RT, Rinaldo CR, Thielman N, Li XD, Wahl SM, Shore J, Janik J, Lempicki RA, Simpson Y, Pollard RB. PMID: 20420510.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCellsCTClinical Trials
    47. Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV. J Acquir Immune Defic Syndr. 2010 May 01; 54(1):59-62. Schacker TW, Bosch RJ, Bennett K, Pollard R, Robbins GK, Collier AC, Gulick RM, Spritzler J, Mildvan D. PMID: 20182359.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    48. Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174. AIDS Res Hum Retroviruses. 2010 Apr; 26(4):425-32. Smith K, Zheng L, Bosch R, Margolis DM, Tenorio A, Napolitano L, Saag M, Connick E, Gross B, Francis I, Valdez H, Muurahainen N, Stocker V, Pollard R. PMID: 20415638.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    49. Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects. J Infect Dis. 2009 Aug 15; 200(4):614-8. Gupta SK, Komarow L, Gulick RM, Pollard RB, Robbins GK, Franceschini N, Szczech LA, Koletar SL, Kalayjian RC. PMID: 19591572.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    50. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial. Lancet. 2009 Sep 05; 374(9692):796-806. Lennox JL, DeJesus E, Lazzarin A, Pollard RB, Madruga JV, Berger DS, Zhao J, Xu X, Williams-Diaz A, Rodgers AJ, Barnard RJ, Miller MD, DiNubile MJ, Nguyen BY, Leavitt R, Sklar P. PMID: 19647866.
      View in: PubMed   Mentions: 160     Fields:    Translation:HumansCellsCTClinical Trials
    51. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med. 2009 Aug; 15(8):955-9. Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, Wen TF, Lindsay RJ, Orellana L, Mildvan D, Bazner S, Streeck H, Alter G, Lifson JD, Carrington M, Bosch RJ, Robbins GK, Altfeld M. PMID: 19597505.
      View in: PubMed   Mentions: 192     Fields:    Translation:HumansCells
    52. Inhibitory effect of glycyrrhizin on the neutrophil-dependent increase of R5 HIV replication in cultures of macrophages. Immunol Cell Biol. 2009 Oct; 87(7):554-8. Yoshida T, Kobayashi M, Li XD, Pollard RB, Suzuki F. PMID: 19529000.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    53. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. AIDS. 2009 Mar 13; 23(5):605-10. Stapleton JT, Chaloner K, Zhang J, Klinzman D, Souza IE, Xiang J, Landay A, Fahey J, Pollard R, Mitsuyasu R. PMID: 19194270.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    54. Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects. J Acquir Immune Defic Syndr. 2009 Mar 01; 50(3):250-8. Skowron G, Spritzler JG, Weidler J, Robbins GK, Johnson VA, Chan ES, Asmuth DM, Gandhi RT, Lie Y, Bates M, Pollard RB. PMID: 19194319.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    55. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis. 2009 Feb 01; 48(3):350-61. Robbins GK, Spritzler JG, Chan ES, Asmuth DM, Gandhi RT, Rodriguez BA, Skowron G, Skolnik PR, Shafer RW, Pollard RB. PMID: 19123865.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCells
    56. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood. 2009 Apr 23; 113(17):3978-89. Ferre AL, Hunt PW, Critchfield JW, Young DH, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL. PMID: 19109229.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCells
    57. The effect of aging on T-regulatory cell frequency in HIV infection. Clin Immunol. 2009 Mar; 130(3):298-303. Tenorio AR, Spritzler J, Martinson J, Gichinga CN, Pollard RB, Lederman MM, Kalayjian RC, Landay AL. PMID: 19008157.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    58. Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status. PLoS One. 2008; 3(10):e3577. Critchfield JW, Young DH, Hayes TL, Braun JV, Garcia JC, Pollard RB, Shacklett BL. PMID: 18974782.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    59. In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits. Clin Vaccine Immunol. 2008 Sep; 15(9):1398-409. Weinberg A, Spritzler J, Nokta M, Schrier R, Landay A, Brown D, Pollard R. PMID: 18579698.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    60. A cytomegalovirus vaccine for transplantation: are we closer? J Infect Dis. 2008 Jun 15; 197(12):1631-3. Go V, Pollard RB. PMID: 18444884.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    61. Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques. J Med Primatol. 2008 Feb; 37(1):26-30. Asmuth DM, Abel K, George MD, Dandekar S, Pollard RB, Miller CJ. PMID: 18199069.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    62. Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy. J Interferon Cytokine Res. 2008 Feb; 28(2):89-100. Davey RT, Pertel PE, Benson A, Cassell DJ, Gazzard BG, Holodniy M, Lalezari JP, Levy Y, Mitsuyasu RT, Palella FJ, Pollard RB, Rajagopalan P, Saag MS, Salata RA, Sha BE, Choudhri S. PMID: 18279104.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    63. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328. Arch Intern Med. 2007 Mar 26; 167(6):597-605. Mitsuyasu R, Gelman R, Cherng DW, Landay A, Fahey J, Reichman R, Erice A, Bucy RP, Kilby JM, Lederman MM, Hamilton CD, Lertora J, White BL, Tebas P, Duliege AM, Pollard RB. PMID: 17389292.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    64. Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. J Virol. 2007 Jun; 81(11):5460-71. Critchfield JW, Lemongello D, Walker DH, Garcia JC, Asmuth DM, Pollard RB, Shacklett BL. PMID: 17344302.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    65. Acceleration of R5 HIV replication by polymorphonuclear neutrophils in cultures of macrophages. Immunol Cell Biol. 2007 Apr-May; 85(3):215-9. Yoshida T, Jones VC, Kobayashi M, Li XD, Pollard RB, Suzuki F. PMID: 17213833.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    66. Glycyrrhizin inhibits the manifestations of anti-inflammatory responses that appear in association with systemic inflammatory response syndrome (SIRS)-like reactions. Cytokine. 2006 Sep; 35(5-6):295-301. Takei M, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. PMID: 17113306.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    67. A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024). J Infect Dis. 2006 Dec 15; 194(12):1672-6. Kilby JM, Bucy RP, Mildvan D, Fischl M, Santana-Bagur J, Lennox J, Pilcher C, Zolopa A, Lawrence J, Pollard RB, Habib RE, Sahner D, Fox L, Aga E, Bosch RJ, Mitsuyasu R. PMID: 17109338.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    68. Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138. J Infect Dis. 2006 Dec 15; 194(12):1677-85. Lederman MM, Smeaton L, Smith KY, Rodriguez B, Pu M, Wang H, Sevin A, Tebas P, Sieg SF, Medvik K, Margolis DM, Pollard R, Ertl HC, Valdez H. PMID: 17109339.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    69. Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study. Pharmacogenet Genomics. 2006 Nov; 16(11):837-45. Motsinger AA, Ritchie MD, Shafer RW, Robbins GK, Morse GD, Labbe L, Wilkinson GR, Clifford DB, D'Aquila RT, Johnson VA, Pollard RB, Merigan TC, Hirsch MS, Donahue JP, Kim RB, Haas DW. PMID: 17047492.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    70. Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology. 2006 Nov; 44(5):1110-6. Peters MG, Andersen J, Lynch P, Liu T, Alston-Smith B, Brosgart CL, Jacobson JM, Johnson VA, Pollard RB, Rooney JF, Sherman KE, Swindells S, Polsky B. PMID: 17058225.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    71. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J Acquir Immune Defic Syndr. 2006 Aug 01; 42(4):426-34. Gandhi RT, Spritzler J, Chan E, Asmuth DM, Rodriguez B, Merigan TC, Hirsch MS, Shafer RW, Robbins GK, Pollard RB. PMID: 16810109.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    72. Glycyrrhizin inhibits neutrophil-associated generation of alternatively activated macrophages. Cytokine. 2006 Mar 21; 33(6):317-22. Yoshida T, Tsuda Y, Takeuchi D, Kobayashi M, Pollard RB, Suzuki F. PMID: 16631375.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    73. The safety and tolerability of Z-100 in patients infected with HIV-1. Antivir Ther. 2006; 11(3):297-303. Borucki M, Holodniy M, Pierone G, Ruane P, Steinhart C, Williams S, Slom T, Palella F, Hare CB, Yoshidao Y, Li XD, Pollard RB. PMID: 16759045.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    74. Differential effect of interleukin-2 treatment on primary and secondary immunizations in HIV infected individuals. AIDS. 2005 Nov 18; 19(17):1967-74. Kuekrek H, Schlingmann T, Valdez H, Boehm BO, Pollard RB, Mitsuyasu R, Goebel FD, Lederman MM, Lehmann PV, Tary-Lehmann M. PMID: 16260902.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic Health
    75. Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study. J Infect Dis. 2005 Dec 01; 192(11):1931-42. Haas DW, Smeaton LM, Shafer RW, Robbins GK, Morse GD, Labbe L, Wilkinson GR, Clifford DB, D'Aquila RT, De Gruttola V, Pollard RB, Merigan TC, Hirsch MS, George AL, Donahue JP, Kim RB. PMID: 16267764.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    76. Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 disease. J Infect Dis. 2005 Nov 01; 192(9):1577-87. Kalayjian RC, Spritzler J, Pu M, Landay A, Pollard RB, Stocker V, Harthi LA, Gross BH, Francis IR, Fiscus SA, Tebas P, Bosch RJ, Valcour V, Lederman MM. PMID: 16206072.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    77. Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic ('virostatic') mechanisms. AIDS. 2005 Jul 22; 19(11):1173-81. Lori F, Foli A, Groff A, Lova L, Whitman L, Bakare N, Pollard RB, Lisziewicz J. PMID: 15990570.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    78. Estimating cell death in G(2)M using bivariate BrdUrd/DNA flow cytometry. Cytometry A. 2005 Jul; 66(1):32-40. White RA, Asmuth DM, Lu Y, Wang N, Li XD, Reece L, Pollard RB, Nokta M, Leary JF, Terry NH. PMID: 15915505.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    79. Cell cycle kinetic dysregulation in HIV-infected normal lymphocytes. Cytometry A. 2005 Jul; 66(1):41-51. Asmuth DM, Wang N, Lu Y, Li XD, Reece L, Terry NH, Pollard RB, Nokta M, Leary JF, White RA. PMID: 15915506.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    80. Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency. AIDS Res Hum Retroviruses. 2005 Apr; 21(4):263-72. Lori F, Pollard RB, Whitman L, Bakare N, Blick G, Shalit P, Foli A, Peterson D, Tennenberg A, Schrader S, Rashbaum B, Farthing C, Herman D, Norris D, Greiger P, Frank I, Groff A, Lova L, Asmuth D, Lisziewicz J. PMID: 15943568.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    81. Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals. Clin Pharmacokinet. 2005; 44(1):99-109. Smith PF, Dicenzo R, Forrest A, Shelton M, Friedland G, Para M, Pollard R, Fischl M, DiFrancesco R, Morse GD. PMID: 15634033.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    82. Glycyrrhizin inhibits R5 HIV replication in peripheral blood monocytes treated with 1-methyladenosine. Pathobiology. 2005; 72(3):117-23. Takei M, Kobayashi M, Li XD, Pollard RB, Suzuki F. PMID: 15860928.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    83. A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis. Antiviral Res. 2004 Nov; 64(2):103-11. Borucki MJ, Spritzler J, Asmuth DM, Gnann J, Hirsch MS, Nokta M, Aweeka F, Nadler PI, Sattler F, Alston B, Nevin TT, Owens S, Waterman K, Hubbard L, Caliendo A, Pollard RB. PMID: 15498605.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    84. Treatments for hepatitis B. Clin Infect Dis. 2004 Nov 01; 39(9):1353-62. Asmuth DM, Nguyen HH, Melcher GP, Cohen SH, Pollard RB. PMID: 15494913.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    85. Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. J Acquir Immune Defic Syndr. 2004 Oct 01; 37(2):1253-62. Hendrix CW, Collier AC, Lederman MM, Schols D, Pollard RB, Brown S, Jackson JB, Coombs RW, Glesby MJ, Flexner CW, Bridger GJ, Badel K, MacFarland RT, Henson GW, Calandra G. PMID: 15385732.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansCellsCTClinical Trials
    86. Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with IL-12. AIDS. 2004 May 21; 18(8):1203-6. Sha BE, Onorato M, Bartlett JA, Bosch RJ, Aga E, Nokta M, Adams EM, Li XD, Eldridge J, Pollard RB. PMID: 15166537.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    87. Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248). J Acquir Immune Defic Syndr. 2004 May 01; 36(1):576-87. Vogler MA, Teppler H, Gelman R, Valentine F, Lederman MM, Pomerantz RJ, Pollard RB, Cherng DW, Gonzalez CJ, Squires KE, Frank I, Mildvan D, Mahon LF, Schock B. PMID: 15097300.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    88. Results of a cytomegalovirus (CMV)-specific CD8+/interferon- gamma+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in patients with AIDS with CMV retinitis. J Infect Dis. 2004 Apr 15; 189(8):1362-73. Jacobson MA, Maecker HT, Orr PL, D'Amico R, Van Natta M, Li XD, Pollard RB, Bredt BM. PMID: 15073672.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    89. Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients. Antimicrob Agents Chemother. 2004 Jan; 48(1):116-23. Wood R, Arasteh K, Stellbrink HJ, Teofilo E, Raffi F, Pollard RB, Eron J, Yeo J, Millard J, Wire MB, Naderer OJ. PMID: 14693528.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    90. Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med. 2003 Dec 11; 349(24):2293-303. Robbins GK, De Gruttola V, Shafer RW, Smeaton LM, Snyder SW, Pettinelli C, Dubé MP, Fischl MA, Pollard RB, Delapenha R, Gedeon L, van der Horst C, Murphy RL, Becker MI, D'Aquila RT, Vella S, Merigan TC, Hirsch MS. PMID: 14668455.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCellsCTClinical Trials
    91. Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients. BMC Infect Dis. 2003 Jun 10; 3:10. Nadler JP, Gathe JC, Pollard RB, Richmond GJ, Liao Q, Griffith S, Lancaster CT, Hernandez JE, Pappa KA. PMID: 12795812.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    92. Soluble IL-4 receptor improves the skin-graft-associated cytomegalovirus infection in thermally injured mice. Burns. 2003 Jun; 29(4):315-21. Kobayashi H, Kobayashi M, Takahashi H, Herndon DN, Pollard RB, Suzuki F. PMID: 12781608.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    93. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis. 2003 Jun 15; 187(12):1924-33. Kalayjian RC, Landay A, Pollard RB, Taub DD, Gross BH, Francis IR, Sevin A, Pu M, Spritzler J, Chernoff M, Namkung A, Fox L, Martinez A, Waterman K, Fiscus SA, Sha B, Johnson D, Slater S, Rousseau F, Lederman MM. PMID: 12792869.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCells
    94. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology. 2003 May 13; 60(9):1508-14. Simpson DM, McArthur JC, Olney R, Clifford D, So Y, Ross D, Baird BJ, Barrett P, Hammer AE. PMID: 12743240.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    95. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature. Int J STD AIDS. 2003 May; 14(5):350-5. Rossero R, Asmuth DM, Grady JJ, McKinsey DS, Green S, Andron L, Pollard RB. PMID: 12803944.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    96. Therapeutic effects of IL-12 combined with benzoylmesaconine, a non-toxic aconitine-hydrolysate, against herpes simplex virus type 1 infection in mice following thermal injury. Burns. 2003 Feb; 29(1):37-42. Kobayashi M, Takahashi H, Herndon DN, Pollard RB, Suzuki F. PMID: 12543043.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    97. Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s. J Infect Dis. 2003 Jan 15; 187(2):320-5. Valdez H, Mitsuyasu R, Landay A, Sevin AD, Chan ES, Spritzler J, Kalams SA, Pollard RB, Fahey J, Fox L, Namkung A, Estep S, Moss R, Sahner D, Lederman MM. PMID: 12552459.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    98. A combination therapy using IL-12 and soluble IL-4 receptor on herpes simplex virus Type 1 infection in a human-SCID chimera model of thermal injury. Clin Immunol. 2002 Dec; 105(3):363-70. Katakura T, Kobayashi M, Fujita K, Herndon DN, Pollard RB, Suzuki F. PMID: 12498818.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    99. An essential role of macrophage inflammatory protein 1alpha/CCL3 on the expression of host's innate immunities against infectious complications. J Leukoc Biol. 2002 Dec; 72(6):1190-7. Takahashi H, Tashiro T, Miyazaki M, Kobayashi M, Pollard RB, Suzuki F. PMID: 12488501.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    100. Entrapment of recent thymic emigrants in lymphoid tissues from HIV-infected patients: association with HIV cellular viral load. AIDS. 2002 Nov 08; 16(16):2119-27. Nokta MA, Li XD, Al-Harthi L, Nichols J, Pou A, Asmuth D, Landay A, Pollard RB. PMID: 12409732.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    101. Inhibitory effect of glycyrrhizin on experimental pulmonary metastasis in mice inoculated with B16 melanoma. Anticancer Res. 2002 Nov-Dec; 22(6C):4053-8. Kobayashi M, Fujita K, Katakura T, Utsunomiya T, Pollard RB, Suzuki F. PMID: 12553032.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    102. Can HIV infection be treated successfully with a once-daily regimen? AIDS Read. 2002 Nov; 12(11):489-90, 494-8, 500, 508. Pollard RB. PMID: 12498154.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    103. An increase in the susceptibility of burned patients to infectious complications due to impaired production of macrophage inflammatory protein 1 alpha. J Immunol. 2002 Oct 15; 169(8):4460-6. Kobayashi M, Takahashi H, Sanford AP, Herndon DN, Pollard RB, Suzuki F. PMID: 12370381.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    104. Effect of a combination therapy between IL-12 and soluble IL-4 receptor (sIL-4R) on Candida albicans and herpes simplex virus type I infections in thermally injured mice. Can J Microbiol. 2002 Oct; 48(10):886-94. Kobayashi M, Takahashi H, Herndon DN, Pollard RB, Suzuki F. PMID: 12489778.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    105. A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298). AIDS Res Hum Retroviruses. 2002 Jul 01; 18(10):699-704. Pollard RB, Tierney C, Havlir D, Tebas P, Fox L, Smeaton L, Richman D, Friedland GH. PMID: 12167276.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    106. Appearance of monocyte chemoattractant protein 1 (MCP-1) early after thermal injury: role in the subsequent development of burn-associated type 2 T-cell responses. Ann Surg. 2002 Jul; 236(1):112-9. Furukawa K, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. PMID: 12131093.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    107. Cryptococcal encephalitis in thermally injured mice is accelerated by type 2 T-cell responses. Crit Care Med. 2002 Jul; 30(7):1419-24. Furukawa K, Kobayashi M, Sasaki H, Herndon DN, Pollard RB, Suzuki F. PMID: 12130955.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    108. Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2. AIDS Res Hum Retroviruses. 2002 Jun 10; 18(9):661-5. Sha BE, Valdez H, Gelman RS, Landay AL, Agosti J, Mitsuyasu R, Pollard RB, Mildvan D, Namkung A, Ogata-Arakaki DM, Fox L, Estep S, Erice A, Kilgo P, Walker RE, Bancroft L, Lederman MM. PMID: 12079562.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    109. Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease. J Infect Dis. 2002 Jun 15; 185(12):1717-22. Nokta MA, Holland F, De Gruttola V, Emery VC, Jacobson MA, Griffiths P, Pollard RB, Feinberg JE. PMID: 12085316.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    110. A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection. AIDS. 2002 May 24; 16(8):1147-54. Jacobson MA, Spritzler J, Landay A, Chan E, Katzenstein D, Schock B, Fox L, Roe J, Kundu S, Pollard R. PMID: 12004273.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    111. Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS. 2002 Feb 15; 16(3):407-12. Simpson DM, Haidich AB, Schifitto G, Yiannoutsos CT, Geraci AP, McArthur JC, Katzenstein DA. PMID: 11834952.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsCTClinical Trials
    112. Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients. Pathobiology. 2002-2003; 70(4):229-36. Sasaki H, Takei M, Kobayashi M, Pollard RB, Suzuki F. PMID: 12679601.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    113. Susceptibility of thermally injured mice to cytomegalovirus infection. Burns. 2001 Nov; 27(7):675-80. Kobayashi H, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. PMID: 11600246.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    114. Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946). AIDS Res Hum Retroviruses. 2001 Oct 10; 17(15):1371-8. Kundu-Raychaudhuri S, Sevin A, Kilgo P, Nokta M, Pollard RB, Merigan TC. PMID: 11679149.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCellsPHPublic HealthCTClinical Trials
    115. Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses. J Leukoc Biol. 2001 Sep; 70(3):374-80. Nakajima H, Kobayashi M, Pollard RB, Suzuki F. PMID: 11527986.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    116. Efficacy of nevirapine-based HAART in HIV-1-infected, treatment-naive persons with high and low baseline viral loads. HIV Clin Trials. 2001 Jul-Aug; 2(4):317-22. Raffi F, Reliquet V, Podzamczer D, Pollard RB. PMID: 11590534.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    117. Glycyrrhizin restores the impaired IL-12 production in thermally injured mice. Cytokine. 2001 Apr 07; 14(1):49-55. Utsunomiya T, Kobayashi M, Ito M, Herndon DN, Pollard RB, Suzuki F. PMID: 11298492.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    118. A mechanism of interleukin-12 unresponsiveness associated with thermal injury. J Surg Res. 2001 Apr; 96(2):211-7. Utsunomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. PMID: 11266275.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    119. Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions. J Acquir Immune Defic Syndr. 2001 Apr 01; 26(4):320-5. Para MF, Kalish LA, Collier AC, Pollard RB, Kumar PN, Mintz L, Wallach FR, Drew WL. PMID: 11317072.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    120. Homeostasis of naive and memory T cell subpopulations in peripheral blood and lymphoid tissues in the context of human immunodeficiency virus infection. J Infect Dis. 2001 May 01; 183(9):1336-42. Nokta MA, Li XD, Nichols J, Pou A, Asmuth D, Pollard RB. PMID: 11294664.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    121. Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals. AIDS. 2001 Jan 26; 15(2):161-9. Nokta MA, Li XD, Nichols J, Mallen M, Pou A, Asmuth D, Pollard RB. PMID: 11216923.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    122. Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice. Pathobiology. 2001; 69(2):96-103. Sasaki H, Kobayashi M, Pollard RB, Suzuki F. PMID: 11752903.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    123. Didanosine once daily: potential for expanded use. AIDS. 2000 Nov 10; 14(16):2421-8. Pollard RB. PMID: 11101051.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    124. A pathogenic role of Th2 responses on the severity of encephalomyelitis induced in mice by herpes simplex virus type 2 infection. J Neuroimmunol. 2000 Oct 02; 110(1-2):106-13. Nakajima H, Kobayashi M, Pollard RB, Suzuki F. PMID: 11024539.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    125. Lanoconazole, a new imidazole antimycotic compound, protects MAIDS mice against encephalitis caused by Cryptococcus neoformans. J Antimicrob Chemother. 2000 Sep; 46(3):443-50. Furukawa K, Sasaki H, Pollard RB, Suzuki F. PMID: 10980172.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    126. Influence of type 2 T cell responses on the severity of encephalitis associated with influenza virus infection. J Leukoc Biol. 2000 Aug; 68(2):180-6. Kaji M, Kobayashi M, Pollard RB, Suzuki F. PMID: 10947061.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    127. In vivo antagonism with zidovudine plus stavudine combination therapy. J Infect Dis. 2000 Jul; 182(1):321-5. Havlir DV, Tierney C, Friedland GH, Pollard RB, Smeaton L, Sommadossi JP, Fox L, Kessler H, Fife KH, Richman DD. PMID: 10882616.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCellsCTClinical Trials
    128. Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS-associated type 2 T cell responses. Clin Immunol. 2000 May; 95(2):145-55. Utsunomiya T, Kobayashi M, Ito M, Pollard RB, Suzuki F. PMID: 10779408.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    129. Neutralization profiles of sera from human immunodeficiency virus (HIV)-infected individuals: relationship to HIV viral load and CD4 cell count. Clin Diagn Lab Immunol. 2000 May; 7(3):412-6. Nokta M, Turk P, Loesch K, Pollard RB. PMID: 10799454.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    130. Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: implications for multicenter clinical trials. The ACTG Immunology Advanced Technology Laboratories. Clin Diagn Lab Immunol. 2000 May; 7(3):352-9. Reimann KA, Chernoff M, Wilkening CL, Nickerson CE, Landay AL. PMID: 10799445.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    131. Analogy of human immunodeficiency virus to hepatitis C virus: the human immunodeficiency model. Am J Med. 1999 Dec 27; 107(6B):41S-44S. Pollard RB. PMID: 10653455.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    132. Cytokine production by rabbit alveolar macrophages: differences between activated and suppressor cell phenotypes. Immunol Lett. 1999 Sep 01; 69(3):339-46. Kobayashi H, Kobayashi M, Heming TA, Bidani A, Pollard RB, Suzuki F. PMID: 10528798.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    133. Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3. J Acquir Immune Defic Syndr. 1999 Sep 01; 22(1):39-48. Pollard RB, Peterson D, Hardy D, Pottage J, Murphy RL, Gathe J, Beall G, Rutkievicz V, Reynolds L, Cross AP, Dunkle LM. PMID: 10534145.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    134. Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team. J Acquir Immune Defic Syndr. 1999 Aug 01; 21(4):281-92. Friedland GH, Pollard R, Griffith B, Hughes M, Morse G, Bassett R, Freimuth W, Demeter L, Connick E, Nevin T, Hirsch M, Fischl M. PMID: 10428106.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsCTClinical Trials
    135. Cadaveric skin allograft-associated cytomegalovirus transmission in a mouse model of thermal injury. Clin Immunol. 1999 Aug; 92(2):181-7. Kobayashi H, Kobayashi M, McCauley RL, Herndon DN, Pollard RB, Suzuki F. PMID: 10444362.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    136. Virological and immunological responses to once-daily dosing of didanosine in combination with stavudine. AI454-143 Team. AIDS. 1999 Jul 30; 13(11):F87-93. Mobley JE, Pollard RB, Schrader S, Adler MH, Kelleher T, McLaren C. PMID: 10449279.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    137. Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice. J Immunol. 1999 Jun 15; 162(12):7148-54. Kobayashi H, Kobayashi M, Utsunomiya T, Herndon DN, Pollard RB, Suzuki F. PMID: 10358160.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    138. [Biological properties of T6S cells, a clone of burn-associated type 2 T cells]. Nihon Rinsho Meneki Gakkai Kaishi. 1999 Jun; 22(3):123-30. Nakajima N, Utsunomiya T, Kobayashi M, Pollard RB, Suzuki F. PMID: 11126663.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    139. Effects of glycyrrhizin, an active component of licorice roots, on Candida albicans infection in thermally injured mice. Clin Exp Immunol. 1999 May; 116(2):291-8. Utsunomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. PMID: 10337021.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    140. Effect of didanosine, stavudine, and hydroxyurea therapy on apoptosis in CD45RA+ and CD45RO+ T lymphocyte subpopulations. AIDS Res Hum Retroviruses. 1999 Feb 10; 15(3):255-64. Nokta M, Rossero R, Nichols J, Rosenbaum M, Pollard RB. PMID: 10052756.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    141. Antiviral effect of gingyo-san, a traditional Chinese herbal medicine, on influenza A2 virus infection in mice. Am J Chin Med. 1999; 27(1):53-62. Kobayashi M, Davis SM, Utsunomiya T, Pollard RB, Suzuki F. PMID: 10354817.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    142. Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. Clin Ther. 1998 Nov-Dec; 20(6):1071-92. Pollard RB, Robinson P, Dransfield K. PMID: 9916603.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    143. A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. J Immunol. 1998 Jun 15; 160(12):5869-73. Kobayashi M, Kobayashi H, Pollard RB, Suzuki F. PMID: 9637498.
      View in: PubMed   Mentions: 25     Fields:    Translation:AnimalsCells
    144. The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine. Part 2: Mechanism of the antiviral action. Immunol Cell Biol. 1998 Jun; 76(3):209-16. Kobayashi M, Kobayashi H, Mori K, Pollard R, Suzuki F. PMID: 9682964.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    145. The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine. Part 1: Antiviral and anti-fungal activities in thermally injured mice. Immunol Cell Biol. 1998 Jun; 76(3):202-8. Kobayashi M, Mori K, Kobayashi H, Pollard RB, Suzuki F. PMID: 9682963.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    146. Burn-associated Candida albicans infection caused by CD30+ type 2 T cells. J Leukoc Biol. 1998 Jun; 63(6):723-31. Kobayashi M, Kobayashi H, Herndon DN, Pollard RB, Suzuki F. PMID: 9620665.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    147. Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 01; 17(3):227-34. Cimoch PJ, Lavelle J, Pollard R, Griffy KG, Wong R, Tarnowski TL, Casserella S, Jung D. PMID: 9495222.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    148. HIV decreases glutamate transport in SK-N-MC neuroblastoma cells. J Neurovirol. 1998 Feb; 4(1):69-79. Pappas TC, Alagarsamy S, Pollard RB, Nokta M. PMID: 9531013.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    149. A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. J Infect Dis. 1998 Jan; 177(1):48-56. Feinberg JE, Hurwitz S, Cooper D, Sattler FR, MacGregor RR, Powderly W, Holland GN, Griffiths PD, Pollard RB, Youle M, Gill MJ, Holland FJ, Power ME, Owens S, Coakley D, Fry J, Jacobson MA. PMID: 9419169.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    150. Kinetics of tumor necrosis factor alpha and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea. AIDS Res Hum Retroviruses. 1997 Dec 10; 13(18):1633-8. Nokta M, Rossero R, Loesch K, Pollard RB. PMID: 9430255.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    151. A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 01; 15(4):283-8. Shepp DH, Ramirez-Ronda C, Dall L, Pollard RB, Murphy RL, Kessler H, Sherer R, Mertz G, Perez G, Gocke DJ, Greenberg SB, Petersen E, Frank I, Moore MD, McKinnis R, Rooney JF. PMID: 9292587.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    152. A relationship between the generation of burn-associated type 2 T cells and their antagonistic cells in thermally injured mice. Burns. 1997 Jun; 23(4):281-7. Utsunomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. PMID: 9248634.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    153. Emerging treatments for viral retinitis. BioDrugs. 1997 Jun; 7(6):423-32. Nokta MA, Hausrath SG, Pollard RB. PMID: 18020490.
      View in: PubMed   Mentions: 1     Fields:    
    154. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet. 1997 May 17; 349(9063):1443-5. Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N, Owens S, Pollard R. PMID: 9164318.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCTClinical Trials
    155. CD4- CD8- TCR alpha/beta+ suppressor T cells demonstrated in mice 1 day after thermal injury. J Trauma. 1997 Apr; 42(4):635-40. Matsuo R, Herndon DN, Kobayashi M, Pollard RB, Suzuki F. PMID: 9137250.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    156. Keishi-ka-kei-to, a traditional Chinese herbal medicine, inhibits pulmonary metastasis of B16 melanoma. Anticancer Res. 1997 Mar-Apr; 17(2A):873-8. Suzuki F, Kobayashi M, Komatsu Y, Kato A, Pollard RB. PMID: 9137420.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    157. Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob Agents Chemother. 1997 Mar; 41(3):551-6. Utsunomiya T, Kobayashi M, Pollard RB, Suzuki F. PMID: 9055991.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    158. Inhibition of pulmonary metastasis by Z-100, an immunomodulatory lipid-arabinomannan extracted from Mycobacterium tuberculosis, in mice inoculated with B16 melanoma. Anticancer Drugs. 1997 Feb; 8(2):156-63. Kobayashi M, Pollard RB, Suzuki F. PMID: 9073311.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    159. In vitro induction of anti-type 2 T cells by glycyrrhizin. Burns. 1996 Dec; 22(8):612-7. Nakajima N, Utsunomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. PMID: 8982539.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    160. A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Nov 01; 13(3):235-46. Japour AJ, Lertora JJ, Meehan PM, Erice A, Connor JD, Griffith BP, Clax PA, Holden-Wiltse J, Hussey S, Walesky M, Cooney E, Pollard R, Timpone J, McLaren C, Johanneson N, Wood K, Booth D, Bassiakos Y, Crumpacker CS. PMID: 8898668.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    161. The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview. Transfusion. 1996 Oct; 36(10):854-9. Busch MP, Collier A, Gernsheimer T, Carrington JD, Flanigan TP, Kashkari M, Kennedy M, Kumar PN, Lane TA, Mellors JW, Mohandas K, Pollard RB, Viele M, Yomtovian R, Holland PV, McCurdy PR. PMID: 8863770.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    162. Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes. J Clin Invest. 1996 Jun 01; 97(11):2635-41. Nokta MA, Hassan MI, Loesch K, Pollard RB. PMID: 8647958.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    163. Interleukin-12 protects thermally injured mice from herpes simplex virus type 1 infection. J Leukoc Biol. 1996 May; 59(5):623-30. Matsuo R, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. PMID: 8656046.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    164. 2-Carboxyethylgermanium sesquioxide, a synthetic organogermanium compound, as an inducer of contrasuppressor T cells. Experientia. 1996 Feb 15; 52(2):159-66. Ikemoto K, Kobayashi M, Fukumoto T, Morimatsu M, Pollard RB, Suzuki F. PMID: 8608818.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    165. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis. 1996 Feb; 22(2):315-21. Sharkey PK, Graybill JR, Johnson ES, Hausrath SG, Pollard RB, Kolokathis A, Mildvan D, Fan-Havard P, Eng RH, Patterson TF, Pottage JC, Simberkoff MS, Wolf J, Meyer RD, Gupta R, Lee LW, Gordon DS. PMID: 8838189.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    166. CMV retinitis: ganciclovir/monoclonal antibody. Antiviral Res. 1996 Jan; 29(1):73-5. Pollard RB. PMID: 8721551.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    167. D4T nucleoside combinations for HIV. Antiviral Res. 1996 Jan; 29(1):101-4. Pollard RB. PMID: 8721558.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    168. Immunotherapy of CMV infections. Adv Exp Med Biol. 1996; 394:145-51. Paar DP, Pollard RB. PMID: 8815681.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    169. The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trials. Control Clin Trials. 1995 Dec; 16(6):408-21. DeMets DL, Fleming TR, Whitley RJ, Childress JF, Ellenberg SS, Foulkes M, Mayer KH, O'Fallon J, Pollard RB, Rahal JJ. PMID: 8720018.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    170. Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1. J Immunol. 1995 Aug 01; 155(3):1326-33. Ikemoto K, Pollard RB, Fukumoto T, Morimatsu M, Suzuki F. PMID: 7636198.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    171. CD4+ contrasuppressor T cells improve the resistance of thermally injured mice infected with HSV. J Leukoc Biol. 1995 Aug; 58(2):159-67. Kobayashi M, Herndon DN, Pollard RB, Suzuki F. PMID: 7643011.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    172. An approach to antiretroviral treatment of HIV disease. New approaches. Hosp Pract (1995). 1995 Aug; 30 Suppl 1:32-40. Pollard RB, Onorato M. PMID: 7543485.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    173. CD8+ type-2 T cells enhance the severity of acute herpes virus infection in mice. Immunol Lett. 1995 Jul-Aug; 47(1-2):63-72. Ikemoto K, Pollard RB, Fukumoto T, Morimatsu M, Suzuki F. PMID: 8537103.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    174. HIV-induced TNF-alpha regulates arachidonic acid and PGE2 release from HIV-infected mononuclear phagocytes. Virology. 1995 Apr 20; 208(2):590-600. Nokta MA, Hassan MI, Loesch KA, Pollard RB. PMID: 7747431.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    175. Zidovudine adherence among individuals with HIV infection. AIDS Care. 1995; 7(4):439-47. Muma RD, Ross MW, Parcel GS, Pollard RB. PMID: 8547359.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    176. Glycyrrhizin (20 beta-carboxy-11-oxo-30-norolean-12-en-3 beta-yl-2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid) improves the resistance of thermally injured mice to opportunistic infection of herpes simplex virus type 1. Immunol Lett. 1995 Jan; 44(1):59-66. Utsunomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. PMID: 7721345.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    177. Protein kinase C and intracellular free Ca++: relationship to human immunodeficiency virus (HIV)-induced cellular hyporesponsiveness. Proc Soc Exp Biol Med. 1994 Dec; 207(3):284-91. Nokta MA, Hassan MI, Morgan JA, Loesch KA, Pollard RB. PMID: 7800684.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    178. Use of proteinase inhibitors in clinical practice. Pharmacotherapy. 1994 Nov-Dec; 14(6 Pt 2):21S-29S. Pollard RB. PMID: 7885982.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    179. Effects of a traditional Chinese herbal medicine, Kanzo-bushi-to, on the resistance of thermally injured mice infected with herpes simplex virus type 1. Int J Immunopharmacol. 1994 Oct; 16(10):855-63. Matsuo R, Ball MA, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. PMID: 7843857.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    180. The antiviral effect of keishi-ni-eppi-ichi-to, a traditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice. Experientia. 1994 Aug 15; 50(8):774-9. Ball MA, Utsunomiya T, Ikemoto K, Kobayashi M, Pollard RB, Suzuki F. PMID: 7520870.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    181. Z-100, a lipid-arabinomannan extracted from Mycobacterium tuberculosis, improves the resistance of thermally injured mice to herpes virus infections. Immunol Lett. 1994 Jun; 40(3):199-205. Kobayashi M, Herndon DN, Pollard RB, Suzuki F. PMID: 7959887.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    182. Protective effect of shigyaku-to, a traditional Chinese herbal medicine, on the infection of herpes simplex virus type 1 (HSV-1) in mice. Experientia. 1994 May 15; 50(5):456-60. Ikemoto K, Utsunomiya T, Ball MA, Kobayashi M, Pollard RB, Suzuki F. PMID: 7910798.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    183. Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL 109): enhancement of in vitro foscarnet- and ganciclovir-induced inhibition of CMV replication. Antiviral Res. 1994 May; 24(1):17-26. Nokta M, Tolpin MD, Nadler PI, Pollard RB. PMID: 7944310.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    184. Effect of a traditional Chinese herbal medicine, kanzo-bushi-to, on the production of interleukin-4 from a clone of burn-associated CD8+ suppressor T cells. Immunol Lett. 1994 Apr; 40(1):13-20. Kobayashi M, Utsunomiya T, Herndon DN, Pollard RB, Suzuki F. PMID: 7927508.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    185. Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group. Ann Intern Med. 1994 Mar 01; 120(5):360-8. Spruance SL, Pavia AT, Peterson D, Berry A, Pollard R, Patterson TF, Frank I, Remick SC, Thompson M, MacArthur RD, Morey GE, Ramirez-Ronda CH, Bernstein BM, Sweet DE, Crane L, Peterson EA, Pachucki CT, Green SL, Brand J, Rios A, Dunkle LM, Cross A, Brown MJ, Ingraham P, Gugliotti R, Schindzielorz AH, Smaldone L. PMID: 7905722.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    186. Parents with human immunodeficiency virus infection: perceptions of their children's emotional needs. Pediatrics. 1994 Mar; 93(3):421-6. Niebuhr VN, Hughes JR, Pollard RB. PMID: 8115201.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    187. Cytomegalovirus DNA polymerase activity and an 80 kDa-associated polypeptide: a potential diagnostic tool for CMV disease. J Virol Methods. 1994 Feb; 46(2):207-22. Hassan MI, Nokta MA, Pollard RB. PMID: 8188815.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    188. Involvement of cAMP and protein kinase C in cytomegalovirus enhancement of human immunodeficiency virus replication. Proc Soc Exp Biol Med. 1993 Nov; 204(2):216-23. Hassan MI, Nokta MA, Pollard RB. PMID: 8415779.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    189. A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group. J Infect Dis. 1993 Sep; 168(3):557-63. Spector SA, Weingeist T, Pollard RB, Dieterich DT, Samo T, Benson CA, Busch DF, Freeman WR, Montague P, Kaplan HJ. PMID: 8394858.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    190. Papaverine hydrochloride: effects on HIV replication and T-lymphocyte cell function. Immunopharmacology. 1993 Sep-Oct; 26(2):181-5. Nokta M, Albrecht T, Pollard R. PMID: 7506701.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    191. Inhibition of burn-associated suppressor cell generation by glycyrrhizin through the induction of contrasuppressor T cells. Immunol Cell Biol. 1993 Jun; 71 ( Pt 3):181-9. Kobayashi M, Schmitt DA, Utsunomiya T, Pollard RB, Suzuki F. PMID: 8349301.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    192. Prolongation of concomitant antitumor immunity in mice treated with Z-100, an arabinomannan extracted from Mycobacterium tuberculosis. Nat Immun. 1993 May-Jun; 12(3):152-64. Sasaki H, Schmitt DA, Kobayashi M, Hayashi Y, Pollard RB, Suzuki F. PMID: 8329838.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    193. Clostridium difficile diarrhea in patients with AIDS versus non-AIDS controls. Methods of treatment and clinical response to treatment. J Clin Gastroenterol. 1993 Apr; 16(3):192-4. Cozart JC, Kalangi SS, Clench MH, Taylor DR, Borucki MJ, Pollard RB, Soloway RD. PMID: 8505488.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    194. Antitumor mechanisms of Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: the importance of lymphocytes infiltrated into tumor sites. Nat Immun. 1993 Mar-Apr; 12(2):104-12. Sasaki H, Schmitt D, Hayashi Y, Pollard RB, Suzuki F. PMID: 8318815.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    195. Demonstrations of a B-cell population that regulates the immune response in spleens of mice infected with herpes simplex virus type I. Clin Immunol Immunopathol. 1993 Feb; 66(2):169-75. Sasaki H, Schmitt DA, Matsumoto K, Pollard RB, Suzuki F. PMID: 8453787.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    196. Immunomodulating activities of orally administered SMANCS, a polymer-conjugated derivative of the proteinaceous antibiotic neocarzinostatin, in an oily formulation. Int J Immunopharmacol. 1993 Feb; 15(2):175-83. Suzuki F, Matsumoto K, Schmitt DA, Pollard RB, Maeda H. PMID: 7682198.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    197. Antitumor activity of orally administered SMANCS, a polymer-conjugated protein drug, in mice bearing various murine tumors. Anticancer Res. 1992 Nov-Dec; 12(6B):2219-24. Schmitt DA, Kisanuki K, Kimura S, Oka K, Pollard RB, Maeda H, Suzuki F. PMID: 1295469.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    198. Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots. In Vivo. 1992 Nov-Dec; 6(6):589-96. Suzuki F, Schmitt DA, Utsunomiya T, Pollard RB. PMID: 1296807.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCellsPHPublic Health
    199. Antiviral effects of recombinant human tumor necrosis factor-alpha in combination with natural interferon-beta in mice infected with herpes simplex virus type 1. Antiviral Res. 1992 Oct 01; 19(4):347-52. Schmitt DA, Sasaki H, Pollard RB, Suzuki F. PMID: 1463323.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    200. Transforming growth factor-beta in the regulation of the immune response. Clin Immunol Immunopathol. 1992 Oct; 65(1):1-9. Sasaki H, Pollard RB, Schmitt D, Suzuki F. PMID: 1395120.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    201. Human immunodeficiency virus replication: modulation by cellular levels of cAMP. AIDS Res Hum Retroviruses. 1992 Jul; 8(7):1255-61. Nokta MA, Pollard RB. PMID: 1381600.
      View in: PubMed   Mentions: 13     Fields:    Translation:Cells
    202. X-irradiation enhances in vitro human immunodeficiency virus replication correlation with cellular levels of cAMP. Proc Soc Exp Biol Med. 1992 Jul; 200(3):402-8. Nokta M, Belli J, Pollard R. PMID: 1352047.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    203. Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group. J Infect Dis. 1992 Mar; 165(3):450-5. Whitley RJ, Gnann JW, Hinthorn D, Liu C, Pollard RB, Hayden F, Mertz GJ, Oxman M, Soong SJ. PMID: 1538151.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    204. Inhibition of tumor growth by the intralesional administration of interleukin-3 into mice implanted with solid tumors. Anticancer Res. 1992 Mar-Apr; 12(2):313-5. Sasaki H, Schmitt DA, Hayashi Y, Pollard RB, Suzuki F. PMID: 1580549.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    205. Analysis and perspective from the infectious disease department. Arch Otolaryngol Head Neck Surg. 1992 Jan; 118(1):19-20. Pollard RB. PMID: 1728273.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    206. Preventive effect of a synthetic immunomodulator, 2-carboxyethylgermanium sesquioxide, on the generation of suppressor macrophages in mice immunized with allogeneic lymphocytes. Immunopharmacol Immunotoxicol. 1992; 14(4):841-64. Kobayashi H, Aso H, Ishida N, Maeda H, Schmitt DA, Pollard RB, Suzuki F. PMID: 1294625.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCellsPHPublic Health
    207. Recombinant human interferon beta ser protects against zidovudine-induced genetic damage in AIDS patients. Antiviral Res. 1991 Sep; 16(2):205-12. Shafik HM, Nokta MA, Pollard RB. PMID: 1799278.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    208. Metabolic interaction of recombinant interferon-beta and zidovudine in AIDS patients. J Interferon Res. 1991 Jun; 11(3):159-64. Nokta M, Loh JP, Douidar SM, Ahmed AE, Pollard RB. PMID: 1919075.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    209. In vivo administration of tumor necrosis factor-alpha is associated with antiviral activity in human peripheral mononuclear cells. Proc Soc Exp Biol Med. 1991 Jun; 197(2):144-9. Nokta M, Matzke D, Jennings M, Schlick E, Nadler PI, Pollard R. PMID: 1709503.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    210. Comparative disposition and whole-body autoradiographic distribution of [2-14C]azidothymidine and [2-14C]thymidine in mice. J Pharmacol Exp Ther. 1991 Apr; 257(1):479-86. Ahmed AE, Jacob S, Loh JP, Samra SK, Nokta M, Pollard RB. PMID: 2020004.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    211. Human immunodeficiency virus infection: association with altered intracellular levels of cAMP and cGMP in MT-4 cells. Virology. 1991 Mar; 181(1):211-7. Nokta M, Pollard R. PMID: 1704657.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    212. Depletion of macrophages expressing I-J antigen results in efficient generation of alloreactive cytotoxic T lymphocytes. Cell Immunol. 1990 Jul; 128(2):589-602. Kobayashi H, Aso H, Ishida N, Maeda H, Pollard RB, Suzuki F. PMID: 2162738.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    213. Induction of interleukin 3 and tumor resistance by SSM, a cancer immunotherapeutic agent extracted from Mycobacterium tuberculosis. Cancer Res. 1990 Jul 01; 50(13):4032-7. Sasaki H, Schmitt D, Hayashi Y, Pollard RB, Suzuki F. PMID: 2354453.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    214. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin. Cancer Res. 1990 Jul 01; 50(13):3897-904. Suzuki F, Pollard RB, Uchimura S, Munakata T, Maeda H. PMID: 2141295.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    215. Patterns of interferon-gamma production by peripheral blood mononuclear cells from patients with human immunodeficiency virus infection. J Interferon Res. 1990 Apr; 10(2):173-81. Nokta MA, Pollard RB. PMID: 1971300.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    216. Release of a mitogenic factor by splenic Lyt 1+ T-cells from mice treated with SSM, an immunomodulator extracted from human type tubercle bacilli. Anticancer Res. 1990 Mar-Apr; 10(2A):285-90. Pollard RB, Schmitt DA, Sasaki H, Hayashi Y, Suzuki F. PMID: 2346302.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    217. Magnetic resonance imaging and neuropsychological findings in human immunodeficiency virus infection. J Acquir Immune Defic Syndr (1988). 1990; 3(8):757-62. Levin HS, Williams DH, Borucki MJ, Hillman GR, Williams JB, Guinto FC, Amparo EG, Crow WN, Pollard RB. PMID: 2366146.
      View in: PubMed   Mentions:
    218. Differential reconstitution of zidovudine-induced inhibition of mitogenic responses by interleukin-2 in peripheral blood mononuclear cells from patients with human immunodeficiency virus infection. Antiviral Res. 1989 May-Jun; 11(4):191-202. Nokta MA, Pollard RB. PMID: 2545165.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    219. Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin. Cancer Immunol Immunother. 1989; 30(2):97-104. Suzuki F, Pollard RB, Maeda H. PMID: 2480846.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    220. Relationship between the production of murine cytomegalovirus and interferon in macrophages. J Gen Virol. 1988 Dec; 69 ( Pt 12):2961-71. Yamaguchi T, Shinagawa Y, Pollard RB. PMID: 2462012.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    221. Suppressor Lyt 2+ T-cells demonstrated in mice late after thermal injury. Immunol Lett. 1988 Sep; 19(1):33-9. Suzuki F, Pollard RB. PMID: 2973435.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    222. Tremor induced by trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988 Jul 01; 109(1):77-8. Borucki MJ, Matzke DS, Pollard RB. PMID: 2967659.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    223. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation. Pediatr Infect Dis J. 1988 May; 7(5 Suppl):S97-102. Pollard RB. PMID: 2456512.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    224. Endoscopic evolution of gastric Kaposi's sarcoma. Gastrointest Endosc. 1987 Dec; 33(6):450-3. Boyd GD, Shabot JM, Pollard RB, Gourley WK. PMID: 3443266.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    225. The use of interferon in the treatment of multiple myeloma. Semin Oncol. 1987 Jun; 14(2 Suppl 2):24-8. Costanzi JJ, Pollard RB. PMID: 3296211.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    226. Suppressor cells generated in mice late after thermal injury. J Trauma. 1987 Apr; 27(4):379-83. Suzuki F, Pollard RB. PMID: 2952804.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    227. Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration. J Clin Oncol. 1987 Feb; 5(2):286-91. Muss HB, Costanzi JJ, Leavitt R, Williams RD, Kempf RA, Pollard R, Ozer H, Zekan PJ, Grunberg SM, Mitchell MS. PMID: 3543247.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    228. Cortisol stimulation by recombinant interferon-alpha 2. J Neuroimmunol. 1986 Oct; 12(4):311-6. Roosth J, Pollard RB, Brown SL, Meyer WJ. PMID: 3760157.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    229. Importance of Lyt 1+ T-cells in the antitumor activity of an immunomodulator, SSM, extracted from human-type Tubercle bacilli. J Natl Cancer Inst. 1986 Aug; 77(2):441-7. Suzuki F, Brutkiewicz RR, Pollard RB. PMID: 3090339.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    230. Assessment of the presence of cytomegalovirus-neutralizing antibody by a plaque-reduction assay. Rev Infect Dis. 1986 Jul-Aug; 8 Suppl 4:S434-8. Lewis RB, Matzke DS, Albrecht TB, Pollard RB. PMID: 3018894.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    231. Suppression of interferon gamma production in mice treated with carrageenan. Eur J Immunol. 1986 Apr; 16(4):375-80. Suzuki F, Maeda H, Pollard RB. PMID: 2938970.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    232. Lack of correlation between antitumour response and serum interferon levels in mice treated with SSM, an immunotherapeutic anticancer agent. Br J Cancer. 1986 Apr; 53(4):567-70. Suzuki F, Brutkiewicz RR, Pollard RB. PMID: 3085702.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    233. Human cytomegalovirus: development and progression of nuclear inclusions by primary clinical isolates and laboratory-adapted strains. Proc Soc Exp Biol Med. 1986 Mar; 181(3):416-22. Fons MP, Graves K, Cavallo T, Pollard R, Albrecht T. PMID: 3003758.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    234. Cooperation of lymphokine(s) and macrophages in expression of antitumor activity of carboxyethylgermanium sesquioxide (Ge-132). Anticancer Res. 1986 Mar-Apr; 6(2):177-82. Suzuki F, Brutkiewicz RR, Pollard RB. PMID: 3085573.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    235. Ability of sera from mice treated with Ge-132, an organic germanium compound, to inhibit experimental murine ascites tumours. Br J Cancer. 1985 Nov; 52(5):757-63. Suzuki F, Brutkiewicz RR, Pollard RB. PMID: 3933536.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    236. Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide (Ge-132). Anticancer Res. 1985 Sep-Oct; 5(5):479-83. Suzuki F, Brutkiewicz RR, Pollard RB. PMID: 3877491.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    237. Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma. J Clin Oncol. 1985 May; 3(5):654-9. Costanzi JJ, Cooper MR, Scarffe JH, Ozer H, Grubbs SS, Ferraresi RW, Pollard RB, Spiegel RJ. PMID: 3998782.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    238. Prevention of suppressed interferon gamma production in thermally injured mice by administration of a novel organogermanium compound, Ge-132. J Interferon Res. 1984; 4(2):223-33. Suzuki F, Pollard RB. PMID: 6431019.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    239. Mechanism for the suppression of gamma-interferon responsiveness in mice after thermal injury. J Immunol. 1982 Nov; 129(5):1811-5. Suzuki F, Pollard RB. PMID: 6214578.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    240. Alterations of interferon production in a mouse model of thermal injury. J Immunol. 1982 Nov; 129(5):1806-10. Suzuki F, Pollard RB. PMID: 6181145.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    241. Specific cell-mediated immunity and infections with herpes viruses in cardiac transplant recipients. Am J Med. 1982 Nov; 73(5):679-87. Pollard RB, Arvin AM, Gamberg P, Rand KH, Gallagher JG, Merigan TC. PMID: 6291387.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    242. Cytomegalovirus immune plasma in bone marrow transplant recipients. Ann Intern Med. 1982 Jul; 97(1):11-8. Winston DJ, Pollard RB, Ho WG, Gallagher JG, Rasmussen LE, Huang SN, Lin CH, Gossett TG, Merigan TC, Gale RP. PMID: 6283982.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCellsCTClinical Trials
    243. Presence of interferon during bacterial otitis media. J Infect Dis. 1982 Jun; 145(6):811-4. Howie V, Pollard RB, Kleyn K, Lawrence B, Peskuric T, Paucker K, Baron S. PMID: 6177803.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    244. Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination. Antimicrob Agents Chemother. 1982 Jan; 21(1):93-100. Sacks SL, Scullard GH, Pollard RB, Gregory PB, Robinson WS, Merigan TC. PMID: 6177285.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    245. Interferons and interferon inducers: development of clinical usefulness and therapeutic promise. Drugs. 1982 Jan-Feb; 23(1-2):37-55. Pollard RB. PMID: 6173188.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    246. Serratia endocarditis in a pediatric burn patient. Cure with cefotaxime. JAMA. 1981 Aug 28; 246(9):983-4. Hyams KC, Mader JT, Pollard RB, Parks DH, Thomson PD, Reinarz JA. PMID: 6265660.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    247. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. J Infect Dis. 1981 Jun; 143(6):772-83. Scullard GH, Pollard RB, Smith JL, Sacks SL, Gregory PB, Robinson WS, Merigan TC. PMID: 6166691.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCellsCTClinical Trials
    248. Usages of interferon and interferon inducers in man: the second half of 1980. Med Biol. 1981 Apr; 59(2):69-76. Pollard RB. PMID: 6171689.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    249. Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer. Antimicrob Agents Chemother. 1981 Jan; 19(1):193-5. Merigan TC, Gallagher JG, Pollard RB, Arvin AM. PMID: 6166245.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    250. Usages of interferon and interferon inducers in man: the first half of 1980. Med Biol. 1980 Dec; 58(6):293-9. Pollard RB. PMID: 6164882.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    251. Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations. Ann Intern Med. 1980 Nov; 93(5):664-70. Egbert PR, Pollard RB, Gallagher JG, Merigan TC. PMID: 6259980.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    252. Cytomegalovirus retinitis in immunosuppressed hosts. I. Natural history and effects of treatment with adenine arabinoside. Ann Intern Med. 1980 Nov; 93(5):655-64. Pollard RB, Egbert PR, Gallagher JG, Merigan TC. PMID: 6259979.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    253. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma. J Clin Invest. 1980 Apr; 65(4):869-78. Arvin AM, Pollard RB, Rasmussen LE, Merigan TC. PMID: 6244336.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    254. Usages of interferon and interferon inducers in man. Med Biol. 1980 Apr; 58(2):57-62. Pollard RB. PMID: 6159505.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    255. Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responses. Antimicrob Agents Chemother. 1979 Dec; 16(6):781-7. Hafkin B, Pollard RB, Tiku ML, Robinson WS, Merigan TC. PMID: 533259.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    256. Toxicity of vidarabine. JAMA. 1979 Jan 05; 241(1):28-9. Sacks SL, Smith JL, Pollard RB, Sawhney V, Mahol AS, Gregory P, Merigan TC, Robinson WS. PMID: 758490.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    257. Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. N Engl J Med. 1978 May 04; 298(18):981-7. Merigan TC, Rand KH, Pollard RB, Abdallah PS, Jordan GW, Fried RP. PMID: 347294.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCellsCTClinical Trials
    258. Selective impairment of lymphocyte reactivity to varicella-zoster virus antigen among untreated patients with lymphoma. J Infect Dis. 1978 May; 137(5):531-40. Arvin AM, Pollard RB, Rasmussen LE, Merigan TC. PMID: 207782.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    259. Cell-mediated immunity of cytomegalovirus infection in normal subjects and cardiac transplant patients. J Infect Dis. 1978 May; 137(5):541-9. Pollard RB, Rand KH, Arvin AM, Merigan TC. PMID: 207783.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    260. Increased pulmonary superinfections in cardiac-transplant patients undergoing primary cytomegalovirus infection. N Engl J Med. 1978 Apr 27; 298(17):951-3. Rand KH, Pollard RB, Merigan TC. PMID: 205784.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    261. Effect of vidarabine on chronic hepatitis B virus infection. JAMA. 1978 Apr 21; 239(16):1648-50. Pollard RB, Smith JL, Neal A, Gregory PB, Merigan TC, Robinson WS. PMID: 633577.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    262. Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients. Transplant Proc. 1978 Mar; 10(1):241-5. Pollard RB, Merigan TC. PMID: 205021.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    263. Lymphocyte transformation and interferon production as measures of cellular immunity in lymphoma patients. IARC Sci Publ. 1978; (24 Pt 2):745-51. Arvin AM, Pollard RB, Rasmussen LE, Rand KH, Merigan TC. PMID: 221398.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    264. Experience with clinical applications of interferon and interferon inducers. Pharmacology & Therapeutics Part A Chemotherapy Toxicology and Metabolic Inhibitors. 1978 Jan 1; 2(4):783-811. Richard B. Pollard, Thomas C. Merigan. .
      View in: Publisher Site   Mentions:
    265. Cellular immunity and herpesvirus infections in cardiac-transplant patients. N Engl J Med. 1977 Jun 16; 296(24):1372-7. Rand KH, Rasmussen LE, Pollard RB, Arvin A, Merigan TC. PMID: 193008.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    266. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med. 1976 Sep 02; 295(10):517-22. Greenberg HB, Pollard RB, Lutwick LI, Gregory PB, Robinson WS, Merigan TC. PMID: 950957.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCells
    267. Early bilateral eighth nerve involvement in meningococcal meningitis. South Med J. 1976 Mar; 69(3):343-4. Pollard RB. PMID: 176735.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    268. Smoking and respiratory illness in military recruits. Arch Environ Health. 1975 Nov; 30(11):533-7. Pollard RB, Melton LJ, Hoeffler DF, Springer GL, Scheiner EF. PMID: 1217913.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    269. Inappropriate secretion of antidiuretic hormone associated with adenovirus pneumonia. Chest. 1975 Oct; 68(4):589-91. Pollard RB. PMID: 170045.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    270. Epidemiologic survey of rubella in a military recruit population. Am J Epidemiol. 1975 May; 101(5):431-7. Pollard RB, Edwards EA. PMID: 1130403.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    271. Field trial of the efficacy of a previously proposed regimen using minocycline and rifampin sequentially for the elimination of meningococci from healthy carriers. Am J Epidemiol. 1973 Jun; 97(6):394-401. Devine LF, Pollard RB, Krumpe PE, Hoy ES, Mammen RE, Miller CH, Peckinpaugh RO. PMID: 4197420.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    Richard B's Networks
    Concepts (833)
    Derived automatically from this person's publications.
    _
    Co-Authors (49)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _